Dolutegravir versus efavirenz in women starting HIV therapy in late pregnancy (DolPHIN-2): an open-label, randomised controlled trial
Kenneth Kintu, Thokozile R. Malaba, Jesca Nakibuka, Christiana Papamichael, Angela Colbers, Kelly Byrne, Kay Seden, Eva Maria Hodel, Tao Chen, Adelline Twimukye, Josaphat Byamugisha, Helen Reynolds, Victoria Watson, David M. Burger, Duolao Wang, Catriona Waitt, Miriam Taegtmeyer, Catherine Orrell, Mohammed Lamorde, Landon Myer, Saye Khoo
Topics & Concepts
DolutegravirEfavirenzMedicinePregnancyAdverse effectObstetricsGestationViral loadRandomized controlled trialPediatricsPostpartum periodAntiretroviral therapyHuman immunodeficiency virus (HIV)Internal medicineVirologyGeneticsBiologyHIV/AIDS Research and InterventionsHIV/AIDS drug development and treatmentHIV Research and Treatment